SEC-sourced researchBeta
NVAX
NOVAVAX INC
Company comparison ↗
Data passport
- CIK
- 0001000694
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Feb 26, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 983,705,000.0000 | Feb 26, 2026 |
| December 2024 | 682,162,000.0000 | Feb 26, 2026 |
| December 2025 | 1,123,479,000.0000 | Feb 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,123,479,000.0000 | 440,302,000.0000 | -244,635,000.0000 | 1,176,512,000.0000 | 1,304,265,000.0000 | Feb 26, 2026 |
| December 2024 | 682,162,000.0000 | -187,499,000.0000 | -87,263,000.0000 | 1,560,418,000.0000 | 2,184,259,000.0000 | Feb 26, 2026 |
| December 2023 | 983,705,000.0000 | -545,062,000.0000 | -713,967,000.0000 | — | — | Feb 26, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $1.12B | December 2025 | Feb 26, 2026 | 10-K |
| Previous period revenueRevenues | $682.16M | December 2024 | Feb 26, 2026 | 10-K |
| Net incomeNetIncomeLoss | $440.3M | December 2025 | Feb 26, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$244.64M | December 2025 | Feb 26, 2026 | 10-K |
| Total assetsAssets | $1.18B | December 2025 | Feb 26, 2026 | 10-K |
| Total liabilitiesLiabilities | $1.3B | December 2025 | Feb 26, 2026 | 10-K |